Monitoring for progression

OurVoice Vol.18 - No.1

Active surveillance has become a trusted choice for many men with low-risk cancer

Active surveillance (AS) has become a mainstream option for men with early prostate cancer, as more supporting evidence has increased patients’ and physicians’ confidence in the approac

Choosing your surgery

OurVoice Vol.18 - No.1

Techniques differ but all aim for the same goals

Standard surgical options in Canada include open radical retropubic prostatectomy, laparoscopic radical prostatectomy and robot-assisted laparoscopic radical prostatectomy.

New options

OurVoice Vol.18 - No.1

Between standard therapy and active surveillance: are there other choices?

Most cancers that are confined to the prostate will grow very slowly, and in these cases, it’s debatable whether treatment is necessary.

Beams and seeds

OurVoice Vol.18 - No.1

Radiation therapy then, now and in the future

Great strides have been made in radiation therapy over the last few decades, from refinements in the precision of external beam radiation delivery to the development of internal seed implants (brac

The changing landscape

OurVoice Vol.18 - No.1

The history of ADT, its current uses and a glimpse into the future

Hormone therapy or androgen deprivation therapy (ADT) comprises a group of medical treatments designed to deprive prostate cancer cells of the male hormone testosterone.

Living with CRPC

OurVoice Vol.18 - No.1

New therapies give men a whole new outlook

The first organs affected by cancer spread, or metastasis, are usually the pelvic lymph nodes and the bones.

Decision-making

OurVoice Vol.17 - No.3

A Saskatoon program helps men communicate their treatment preferences and values

Prostate cancer is unique in that no other disease condition with a comparably high incidence rate has so many available treatment alternatives — yet so few certainties about which one is bes

Radioactive seeds

OurVoice Vol.17 - No.2

Long-term results make brachytherapy an interesting option for low- and intermediate-risk disease

Radiation is a standard treatment option for men with prostate cancer. It targets both normal tissues and cancer cells, but cancer cells are more sensitive to being killed by the radiation.

The surgical setting

OurVoice Vol.17 - No.1

A look at current techniques and emerging technologies

Surgery is a mainstay in the treatment of prostate cancer.

Into the 21st century

OurVoice Vol.17 - No.1

The high-tech world of prostate radiotherapy

Prostate cancer arises in a small, relatively inaccessible organ located deep in the pelvis, surrounded by sensitive structures like the bladder, rectum and nerves that control erectile function.